VASOPRESSIN
These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014
Approved
Approval ID
0933a550-03f1-0937-e063-6394a90a1e89
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 2, 2023
Manufacturers
FDA
Medical Purchasing Solutions, LLC
DUNS: 601458529
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
VASOPRESSIN
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71872-7306
Application NumberANDA214314
Product Classification
M
Marketing Category
C73584
G
Generic Name
VASOPRESSIN
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 2, 2023
FDA Product Classification
INGREDIENTS (4)
WATERInactive
Code: 059QF0KO0R
Classification: IACT
CHLOROBUTANOLInactive
Code: HM4YQM8WRC
Classification: IACT
VASOPRESSINActive
Quantity: 20 [USP'U] in 1 mL
Code: Y87Y826H08
Classification: ACTIB
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT